CD8 cell PET imaging with 89-Zr-crefmirlimab berdoxam (crefmirlimab) in patients with metastatic renal cell carcinoma (mRCC) receiving checkpoint inhibitors (CPIs): Association with response and tissue CD8 expression.

Authors :: Pal, Sumanta Kumar
Twardowski, Przemyslaw
Chen, Delphine L.
Hall, Evan Thomas
Hays, David
Wilson, Ian
Schmiedehausen, Kristin
Ferris, Michael
Le, William
Postow, Michael A.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p4551-4551, 1p
Publication Year :: 2023

Full Text Access

Tools